These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 10068709)

  • 21. Successful treatment of refractory anemia with a combination regimen containing recombinant human erythropoietin, low-dose methylprednisolone and nandrolone.
    Tsiara SN; Chaidos A; Gouva M; Christou L; Panteli K; Kapsali E; Bourantas KL
    J Exp Clin Cancer Res; 2004 Mar; 23(1):47-52. PubMed ID: 15149150
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Update on the clinical use and misuse of erythropoietin.
    Eagleton HJ; Littlewood TJ
    Curr Hematol Rep; 2003 Mar; 2(2):109-15. PubMed ID: 12901141
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Iron requirements in erythropoietin therapy.
    Eschbach JW
    Best Pract Res Clin Haematol; 2005 Jun; 18(2):347-61. PubMed ID: 15737895
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypochromic red blood cells in low-risk myelodysplastic syndromes: effects of treatment with hemopoietic growth factors.
    Ljung T; Bäck R; Hellström-Lindberg E
    Haematologica; 2004 Dec; 89(12):1446-53. PubMed ID: 15590394
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The treatment of anemia in chronic kidney disease: understandings in 2006.
    Levin A
    Curr Opin Nephrol Hypertens; 2007 May; 16(3):267-71. PubMed ID: 17420672
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Soluble transferrin receptor and erythropoietin in chronic disease anemia with or without iron deficiency].
    Díaz de Domingo NB; Lardo MM; Gasparini S; Grinspon D; Cantenys N; Carbia CD; Merelli A; Sánchez Avalos JC
    Medicina (B Aires); 2001; 61(5 Pt 1):552-6. PubMed ID: 11725764
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anemias of chronic disease in the aged: diagnosis and treatment.
    Damon LE
    Geriatrics; 1992 Apr; 47(4):47-54, 57. PubMed ID: 1555779
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapy insight: congestive heart failure, chronic kidney disease and anemia, the cardio-renal-anemia syndrome.
    Iaina A; Silverberg DS; Wexler D
    Nat Clin Pract Cardiovasc Med; 2005 Feb; 2(2):95-100. PubMed ID: 16265380
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anemia of chronic disease (anemia of inflammation).
    Agarwal N; Prchal JT
    Acta Haematol; 2009; 122(2-3):103-8. PubMed ID: 19907147
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical characteristics of erythropoietin-associated pure red cell aplasia.
    Carson KR; Evens AM; Bennett CL; Luminari S
    Best Pract Res Clin Haematol; 2005; 18(3):467-72. PubMed ID: 15792921
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reticulocyte hemoglobin content.
    Mast AE; Blinder MA; Dietzen DJ
    Am J Hematol; 2008 Apr; 83(4):307-10. PubMed ID: 18027835
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pathogenesis of the anemia of chronic disease: a cytokine-mediated anemia.
    Means RT
    Stem Cells; 1995 Jan; 13(1):32-7. PubMed ID: 7719246
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Advances in the anemia of chronic disease.
    Means RT
    Int J Hematol; 1999 Jul; 70(1):7-12. PubMed ID: 10446488
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anemia of chronic disease and defective erythropoietin production in patients with celiac disease.
    Bergamaschi G; Markopoulos K; Albertini R; Di Sabatino A; Biagi F; Ciccocioppo R; Arbustini E; Corazza GR
    Haematologica; 2008 Dec; 93(12):1785-91. PubMed ID: 18815191
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adding growth factors or interleukin-3 to erythropoietin has limited effects on anemia of transfusion-dependent patients with myelodysplastic syndromes unresponsive to erythropoietin alone.
    Musto P; Sanpaolo G; D'Arena G; Scalzulli PR; Matera R; Falcone A; Bodenizza C; Perla G; Carotenuto M
    Haematologica; 2001 Jan; 86(1):44-51. PubMed ID: 11146570
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anemia and chronic heart failure implications and treatment options.
    Anand IS
    J Am Coll Cardiol; 2008 Aug; 52(7):501-11. PubMed ID: 18687241
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Laboratory evaluation of anemia.
    Wallerstein RO
    West J Med; 1987 Apr; 146(4):443-51. PubMed ID: 3577135
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of i.v. iron alone or in combination with low-dose erythropoietin in the rapid correction of anemia of chronic renal failure in the predialysis period.
    Silverberg DS; Blum M; Agbaria Z; Deutsch V; Irony M; Schwartz D; Baruch R; Yachnin T; Steinbruch S; Iaina A
    Clin Nephrol; 2001 Mar; 55(3):212-9. PubMed ID: 11316241
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Red blood cell membrane lipid peroxidation and resistance to erythropoietin therapy in hemodialysis patients.
    Gallucci MT; Lubrano R; Meloni C; Morosetti M; Manca di Villahermosa S; Scoppi P; Palombo G; Castello MA; Casciani CU
    Clin Nephrol; 1999 Oct; 52(4):239-45. PubMed ID: 10543326
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of anemia in the progression of congestive heart failure. Is there a place for erythropoietin and intravenous iron?
    Silverberg DS; Wexler D; Iaina A
    J Nephrol; 2004; 17(6):749-61. PubMed ID: 15593047
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.